Getting a handle on hidradenitis suppurativa

Kuritzky, Louis
August 2009
Internal Medicine Alert;8/30/2009 Clinical Briefs, p129
The article discusses the characteristics, treatment, and impact to patients with hidradenitis suppurativa (HSP).


Related Articles

  • Bowen's disease. Stollery, Nigel // Pulse;5/5/2003, Vol. 63 Issue 18, p66 

    Presents a questionnaire on Bowen's disease of the skin. Parts of the body which are commonly affected by the disease; Symptoms and manifestations; Comparison with other skin diseases; Treatment.

  • Hydrochlorothiazide-induced Acute Generalized Exanthematous Pustulosis. Pétavy-Catala, C.; Martin, L.; Fontès, V.; Lorette, G.; Vaillant, L. // Acta Dermato-Venereologica;Jun/Jul2001, Vol. 81 Issue 3, p209 

    Focuses on hydrochlorothiazide-induced acute generalized exanthematous pustulosis (AGEP). Condition of a patient suffering from acute febrile cutaneous eruption; Criteria for the diagnosis of AGEP; Risks involved in using antibacterial sulfonamides.

  • Verrucous Carcinoma. Conologue, Theresa Dressler; Lim, Scott; McCollough, Martha // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1808 

    Presents a case report of an old woman with a verrucous carcinoma on her left upper back. Description of the skin disease; Factors which cause verrucous carcinoma; Treatment for the disease.

  • Oritavancin shortens treatment time for complicated skin-structure infections. Prescott, Lawrence M. // Dermatology Times;Mar2002, Vol. 23 Issue 3, p19 

    Presents a study on oritavancin, a treatment for complicated skin infections in the U.S. Announcement of findings at the 41st Interscience Conference on Antimicrobial Agents & Chemotherapy; Investigation on patients provided with therapeutics; Efficacy of doses in patients with diseases.

  • Consider combinations for melasma treatment success. Nataloni, Rochelle // Dermatology Times;May2006, Vol. 27 Issue 5, p43 

    The article reports on the new therapeutic treatment for melasma, a disease affecting 50 percent of pregnancies in the U.S. and was thought to be incurable. Therapies for melasma are becoming increasingly refined by the ability to properly diagnose and pair the most appropriate treatment to each...

  • Vitiligo. Stolley, Nigel // Pulse;10/13/2003, Vol. 63 Issue 41, p66 

    Presents tips for general practitioners on vitiligo diagnosis and treatments. Consideration of the differential diagnosis of Pityriasis versicolor; Recommendation for the prevention of tanning of the adjacent skin; Association of hypopigmented to other skin diseases.

  • Can the Immersion Time of PUVA Bath Therapy be Shortened? Schiener, Ralf; Behrens-Williams, Stefanie C.; Pillekamp, Hans; Kaskel, Peter; Peter, Ralf Uwe; Kerscher, Martina // Acta Dermato-Venereologica;Jan2002, Vol. 82 Issue 1, p18 

    Up to now, there are only a few data available concerning the influence of bathing time on skin phototoxicity. We compared the erythemal responses of normal skin to bath PUVA with 8-methoxypsoralen (8-MOP) after 5, 10 and 20 min immersion time. Currently, 20 min is the routinely performed...

  • Foreword: Emerging Role of Topical Immunomodulatory Therapies in Dermatology. Sauder, Daniel // Journal of Cutaneous Medicine & Surgery;Dec2004 Supplement 3, Vol. 8, p1 

    Focuses on emerging role of topical immunomodulatory therapies in dermatology. Dermatologic conditions considered.

  • Psychodermatology: The Mind and Skin Connection. Koo, John; Lebwohl, Andrew // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1873 

    A psychodermatologic disorder is a condition that involves an interaction between the mind and the skin. Psychodermatologic disorders fall into three categories: psychophysiologic disorders, primary psychiatric disorders and secondary psychiatric disorders. Psychophysiologic disorders (e.g.,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics